Condition
Normotensive
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03948373Not ApplicableRecruitingPrimary
Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern
NCT03987425Not ApplicableCompletedPrimary
Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern
NCT04699110Phase 4Completed
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
Showing all 3 trials